FDA allows spring boosters for some; in one town, abortion debate seems to override everything else

In Bristol, which spans Virginia and Tennessee, an abortion debate is consuming public attention despite an ongoing environmental crisis.

April 18, 2023 Check out STAT+

Sponsored By

Mike Belleme for STAT In a town plagued by an environmental crisis, a local abortion debate consumes public attention In Bristol, which spans Virginia and Tennessee, an abortion debate is consuming public attention despite an ongoing environmental crisis. By Eric Boodman FDA says older adults and the immunocompromised may get a spring booster dose of Covid vaccine The immunocompromised may also receive an additional dose of Covid-19 vaccine, the FDA said in a statement. By Helen Branswell STAT+ | Novel strategy of attacking sugars on cancer cells to free immune system shows promise in early tests A drug based on work that won a Nobel Prize passes a safety trial. Its aim is to boost the immune system to fight a variety of cancers. By Angus Chen Hannah McKay/Getty Images Opinion: Rural hospitals are closing labor and delivery services. Babies' lives are in jeopardy Proximity to labor and delivery services is important not only for the health of pregnant people, but also for the health of their fetuses. By Rachel Fleishman STAT+ | GSK to buy Bellus Health for $2 billion, gaining chronic cough drug With the Bellus Health acquisition, GSK will get the experimental drug camlipixant, which is in a Phase 3 trial for refractory chronic cough. By Andrew Joseph STAT+ | Define Ventures raises $460 million to fuel early-stage health tech startups In 2021, when just about anyone could get funding, ambitions were big and scrutiny was light. That won't fly in 2023. By Mario Aguilar Adobe Opinion: What the recent failures of Mindstrong and Pear tell us about the future of digital mental health The failures of Mindstrong and Pear Therapeutics are symptomatic of problems with the digital mental health field. By John Torous

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser